Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients

被引:20
|
作者
Kumagai, Junichiro [1 ]
Taide, Takashi [1 ]
Ogasawara, Sadahisa [1 ]
Nakagawa, Tomoo [1 ]
Lino, Yotaro [1 ]
Shingyoji, Ayako [1 ]
Ishikawa, Kentaro [1 ]
Akizue, Naoki [1 ]
Yamato, Mutsumi [1 ]
Takahashi, Koji [1 ]
Ohta, Yuki [1 ]
Hamanaka, Shinsaku [1 ]
Okimoto, Kenichiro [1 ]
Nakamura, Masato [1 ]
Ohyama, Hiroshi [1 ]
Saito, Keiko [1 ]
Kusakabe, Yuko [1 ]
Maruoka, Daisuke [1 ]
Yasui, Shin [1 ]
Matsumura, Tomoaki [1 ]
Sugiyama, Harutoshi [1 ]
Sakai, Yuji [1 ]
Mikata, Rintaro [1 ]
Arai, Makoto [1 ]
Katsuno, Tatsuro [1 ]
Tsuyuguchi, Toshio [1 ]
Kato, Naoya [1 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan
来源
PLOS ONE | 2018年 / 13卷 / 12期
关键词
INFLAMMATORY-BOWEL-DISEASE; INCREASING INCIDENCE; INCREASED RISK; PSC-IBD; POPULATION; PREVALENCE; EPIDEMIOLOGY; DIAGNOSIS; PROGNOSIS; IMPACT;
D O I
10.1371/journal.pone.0209352
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background In Western countries, most patients with primary sclerosing cholangitis (PSC) have concurrent ulcerative colitis (UC). The number of patients with UC in East Asia has increased markedly over the past two decades. However, current clinical features of PSC and of PSC associated with UC (PSC-UC) have not yet been clarified in East Asia, particularly in Japan. We aimed to reveal the clinical courses and associations with UC in Japanese patients with PSC from the mutual viewpoint of PSC and UC. Methods We retrospectively retrieved medical records of patients with PSC (69) and UC (1242) who were diagnosed at Chiba University Hospital between June 1991 and August 2017. Results In the present cohort, 37 patients had PSC-UC; the cumulative risks of PSC in patients with UC and of UC in patients with PSC were 3.0% and 53.6%, respectively. We confirmed similar distinctive results by a Japanese nationwide survey, noting that younger patients with PSC had a notably high possibility of association with UC. From the viewpoint of the UC cohort, the occurrence of right-sided disease was significantly higher in patients with PSCUC than in those with UC (16.2% vs. 4.2%, P = 0.003). Pancolitis was more commonly observed in PSC-UC, and proctits/left-sided colitis was less commonly found in patients with UC. The number of patients with young-onset PSC-UC may be increasing similar to an increase in patients with UC in Japan. Conclusions In our cohort, the comorbidity rate of PSC-UC was higher than that obtained in previous reports. The incidence of PSC-UC and UC may increase in the future in East Asia, particularly in Japan.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis
    In Sub Han
    Dong Hoon Baek
    Seung Min Hong
    Bong Eun Lee
    Moon Won Lee
    Gwang Ha Kim
    Geun Am Song
    International Journal of Colorectal Disease, 38
  • [22] Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis
    de Krijger, Manon
    Hageman, Ishtu L.
    Li Yim, Andrew Y. F.
    Verhoeff, Jan
    Vallejo, Juan J. Garcia
    van Hamersveld, Patricia H. P.
    Levin, Evgeni
    Hakvoort, Theodorus B. M.
    Wildenberg, Manon E.
    Henneman, Peter
    Ponsioen, Cyriel Y.
    de Jonge, Wouter J.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis
    Han, In Sub
    Baek, Dong Hoon
    Hong, Seung Min
    Lee, Bong Eun
    Lee, Moon Won
    Kim, Gwang Ha
    Song, Geun Am
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2023, 38 (01)
  • [24] Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn's disease
    Navaneethan, Udayakumar
    Venkatesh, Preethi G. K.
    Jegadeesan, Ramprasad
    Lourdusamy, Vennisvasanth
    Hammel, Jeffrey P.
    Kiran, Ravi P.
    Shen, Bo
    GASTROENTEROLOGY REPORT, 2016, 4 (01): : 43 - 49
  • [25] Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis
    Leidenius, MHK
    Farkkila, MA
    Karkkainen, P
    Taskinen, EI
    Kellokumpu, IH
    Hockerstedt, KAV
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (07) : 706 - 711
  • [26] COLORECTAL NEOPLASIA IN PATIENTS WITH ULCERATIVE-COLITIS AND PRIMARY SCLEROSING CHOLANGITIS
    GURBUZ, AK
    GIARDIELLO, FM
    BAYLESS, TM
    DISEASES OF THE COLON & RECTUM, 1995, 38 (01) : 37 - 41
  • [27] The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis
    Shetty, K
    Rybicki, L
    Brzezinski, A
    Carey, WD
    Lashner, BA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (06): : 1643 - 1649
  • [28] Characterization of colon cancer in patients with primary sclerosing cholangitis and ulcerative colitis
    Thackeray, Erin W.
    Charatcharoenwitthaya, Phunchai
    Lindor, Keith D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S269 - S269
  • [29] Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomy
    Sombat Treeprasertsuk
    Einar Bjrnsson
    Emmanouil Sinakos
    Emma Weeding
    Keith D Lindor
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2013, 4 (03) : 61 - 68
  • [30] ANTILACTOFERRIN ANTIBODIES IN PEDIATRIC PATIENTS: PRIMARY SCLEROSING CHOLANGITIS OR ULCERATIVE COLITIS?
    Bracci, F.
    Girolami, E.
    Diamanti, A.
    Panetta, F.
    Giovannelli, L.
    Daniele, A.
    Bordasco, S.
    Isacchi, G.
    Torre, G.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S341 - S341